| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,159 |
4,526 |
$650K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,711 |
5,101 |
$508K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,445 |
1,343 |
$153K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,381 |
1,287 |
$144K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
878 |
747 |
$81K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
5,528 |
5,087 |
$67K |
| 92552 |
|
2,463 |
2,316 |
$59K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
480 |
449 |
$56K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
798 |
727 |
$44K |
| 90686 |
|
1,611 |
1,494 |
$35K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,040 |
914 |
$17K |
| 90677 |
|
224 |
208 |
$13K |
| 90698 |
|
552 |
506 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
313 |
290 |
$10K |
| 96127 |
|
2,005 |
1,831 |
$9K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
66 |
61 |
$9K |
| 90656 |
|
379 |
359 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
495 |
465 |
$6K |
| 90680 |
|
210 |
187 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
86 |
85 |
$4K |
| 90670 |
|
212 |
190 |
$4K |
| 3008F |
|
1,044 |
1,002 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
174 |
151 |
$4K |
| 94760 |
|
1,859 |
1,666 |
$4K |
| 99173 |
|
1,379 |
1,297 |
$3K |
| 90633 |
|
156 |
136 |
$3K |
| 0001A |
|
75 |
75 |
$3K |
| 83655 |
|
245 |
216 |
$3K |
| 90651 |
|
111 |
107 |
$3K |
| 0002A |
|
64 |
62 |
$2K |
| 90716 |
|
109 |
99 |
$2K |
| 0072A |
|
60 |
60 |
$2K |
| 96160 |
|
826 |
763 |
$2K |
| 90744 |
|
86 |
82 |
$2K |
| 90707 |
|
84 |
75 |
$2K |
| 0071A |
|
47 |
44 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
48 |
46 |
$2K |
| 99051 |
|
114 |
103 |
$1K |
| 0073A |
|
32 |
19 |
$1K |
| 85018 |
|
519 |
453 |
$1K |
| 96161 |
|
274 |
230 |
$617.83 |
| 90688 |
|
17 |
17 |
$395.76 |
| 90734 |
|
13 |
13 |
$302.64 |
| 90715 |
|
13 |
13 |
$302.64 |
| 90696 |
|
13 |
12 |
$279.36 |
| 36416 |
|
499 |
386 |
$58.50 |
| 99188 |
|
920 |
844 |
$45.00 |
| 91300 |
|
67 |
59 |
$0.04 |
| 91311 |
|
27 |
24 |
$0.01 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
14 |
14 |
$0.00 |
| 99001 |
|
99 |
90 |
$0.00 |